Latest 10-Q quarterly reports

Petros Pharmaceuticals reports a net loss of $0.99 million for Q1 2026 while continuing to navigate significant going concern risks.

Semnur Pharmaceuticals reported increased losses and negative cash flow for Q1 2026, raising substantial doubt about its going concern ability, while terminating two significant equity financing agreements.

NexMetals Mining Corp. reports Q1 2026 results, highlighting ongoing exploration at its Botswana copper-nickel-cobalt projects and a focus on resource expansion.

Nakamoto Inc. reports a significant net loss for Q1 2026 driven by Bitcoin price volatility and acquisition-related costs as it completes its transition to a Bitcoin-focused operating company.

Palatin Technologies reports Q3 2026 financial results, highlighting revenue growth from strategic licensing agreements and a strengthened cash position.

NMP Acquisition Corp. reports Q1 2026 financial results as it continues its search for an initial business combination target.

Maywood Acquisition Corp. 2 reports Q1 2026 financial results following its April 2026 initial public offering.

TAO Synergies reports Q1 2026 net income of $4.25 million, driven by unrealized gains on its Bittensor (TAO) cryptocurrency treasury holdings.

ClearPoint Neuro reports 43% revenue growth in Q1 2026, driven by IRRAS acquisition and expanded neurosurgical product sales.

American Rebel Holdings, Inc. reports Q1 2026 financial results and announces its transition to OTC Markets following a Nasdaq delisting determination.

Blueport Acquisition Ltd has entered into a definitive merger agreement with SINGAUTO Inc. valued at $1.2 billion in equity.

Global Water Resources reported a net loss of $0.4 million for Q1 2026, driven by increased operating expenses and depreciation despite revenue growth.

Jaws Mustang Acquisition Corporation reports Q1 2026 financial results while continuing to seek a business combination before the December 4, 2026 deadline.

AEI Income & Growth Fund XXI reports Q1 2026 net income of $47,209 as it continues its final liquidation process.

Armata Pharmaceuticals reported a significant net loss of $115.3 million in Q1 2026, raising substantial doubt about its ability to continue as a going concern despite positive clinical trial advancements and a new $25 million loan.

AEI Income & Growth Fund XXII Limited Partnership reported a net loss of $3,559 for Q1 2026, a worsening from the prior year, as it proceeds with its final liquidation process.

Perceptive Capital Solutions Corp reported a net loss in Q1 2026 and is seeking shareholder approval to extend its business combination deadline to June 2027 to complete its proposed merger with Freenome.

Battalion Oil Corporation reported a net loss of $56.5 million for Q1 2026, impacted by derivative losses, while completing a divestiture and an acquisition to reshape its asset base.

MultiSensor AI Holdings reported a 38% increase in revenue for the first quarter of 2026, driven by strong software sales, while net loss narrowed significantly.

SeaStar Medical Holding Corporation reported increased revenue in Q1 2026 driven by QUELIMMUNE adoption, though net losses persisted.

Oaktree Acquisition Corp. III Life Sciences reports net income of $1.39 million for Q1 2026, driven by trust account interest, while continuing its search for a business combination.

Leslies, Inc. reported a 4.3% increase in sales for the second quarter ended April 4, 2026, driven by retail strength and calendar shifts, despite ongoing store closures.

ZyVersa Therapeutics reports a net loss of $1.8 million for Q1 2026, with significant cash burn and ongoing need for financing.

Reviva Pharmaceuticals reports Q1 2026 results, detailing a net loss of $3.2 million and significant cash burn, while preparing for Nasdaq delisting and transition to OTCQB.

Commercial Bancgroup, Inc. announced its first quarter 2026 financial results, showing a 9.7% increase in net income driven by higher net interest income.

Harvard Apparatus Regenerative Technology reports significant revenue growth in its Consumer Health segment while facing ongoing challenges in its regenerative biotech operations, underscoring its need for continued financing.

KLX Energy Services Holdings, Inc. reported a net loss of $24.0 million for the first quarter of 2026, a slight improvement from the prior year, amidst fluctuating oil prices and strategic debt management.

Kaanapali Land, LLC's Q1 2026 results show a dramatic turnaround driven by a substantial property sale, leading to a significant net income increase and positive cash flow.

Team, Inc. reported an 8.3% increase in total revenues for Q1 2026, driven by growth in both Inspection and Heat-Treating (IHT) and Mechanical Services (MS) segments, while the overall operating loss significantly narrowed.

Genprex reports on progress in its oncology and diabetes gene therapy programs, with increased cash reserves from equity financings and ongoing clinical trial enrollment.